vs
埃克西尔能源（NINE）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是埃克西尔能源的1.7倍（$219.9M vs $132.2M），Orthofix Medical Inc.净利率更高（-1.0% vs -14.5%，领先13.5%），Orthofix Medical Inc.同比增速更快（2.0% vs -6.5%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-4.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -3.6%）
埃克西尔能源是一家受美国监管的电力与天然气配送企业，总部位于明尼苏达州明尼阿波利斯。截至2025年年中，公司业务覆盖八个州的部分区域，服务约390万电力客户与220万天然气客户，下设四家运营子公司，分别为明尼苏达北州电力、威斯康星北州电力、科罗拉多公共服务公司以及西南公共服务公司。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
NINE vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.7倍
$132.2M
营收增速更快
OFIX
高出8.5%
-6.5%
净利率更高
OFIX
高出13.5%
-14.5%
自由现金流更多
OFIX
多$21.6M
$-4.8M
两年增速更快
OFIX
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $132.2M | $219.9M |
| 净利润 | $-19.2M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | -4.2% | 0.2% |
| 净利率 | -14.5% | -1.0% |
| 营收同比 | -6.5% | 2.0% |
| 净利润同比 | -117.4% | 92.4% |
| 每股收益（稀释后） | $-0.47 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NINEOFIX
| Q4 25 | $132.2M | $219.9M | ||
| Q3 25 | $132.0M | $205.6M | ||
| Q2 25 | $147.3M | $203.1M | ||
| Q1 25 | $150.5M | $193.6M | ||
| Q4 24 | $141.4M | $215.7M | ||
| Q3 24 | $138.2M | $196.6M | ||
| Q2 24 | $132.4M | $198.6M | ||
| Q1 24 | $142.1M | $188.6M |
净利润NINEOFIX
| Q4 25 | $-19.2M | $-2.2M | ||
| Q3 25 | $-14.6M | $-22.8M | ||
| Q2 25 | $-10.4M | $-14.1M | ||
| Q1 25 | $-7.1M | $-53.1M | ||
| Q4 24 | $-8.8M | $-29.1M | ||
| Q3 24 | $-10.1M | $-27.4M | ||
| Q2 24 | $-14.0M | $-33.4M | ||
| Q1 24 | $-8.1M | $-36.0M |
毛利率NINEOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率NINEOFIX
| Q4 25 | -4.2% | 0.2% | ||
| Q3 25 | -0.9% | -8.3% | ||
| Q2 25 | 2.3% | -7.9% | ||
| Q1 25 | 3.7% | -25.2% | ||
| Q4 24 | 2.5% | -5.3% | ||
| Q3 24 | 1.8% | -9.6% | ||
| Q2 24 | -1.1% | -12.5% | ||
| Q1 24 | 3.1% | -15.6% |
净利率NINEOFIX
| Q4 25 | -14.5% | -1.0% | ||
| Q3 25 | -11.1% | -11.1% | ||
| Q2 25 | -7.1% | -6.9% | ||
| Q1 25 | -4.7% | -27.4% | ||
| Q4 24 | -6.3% | -13.5% | ||
| Q3 24 | -7.3% | -13.9% | ||
| Q2 24 | -10.6% | -16.8% | ||
| Q1 24 | -5.7% | -19.1% |
每股收益（稀释后）NINEOFIX
| Q4 25 | $-0.47 | $-0.05 | ||
| Q3 25 | $-0.35 | $-0.57 | ||
| Q2 25 | $-0.25 | $-0.36 | ||
| Q1 25 | $-0.18 | $-1.35 | ||
| Q4 24 | $-0.21 | $-0.76 | ||
| Q3 24 | $-0.26 | $-0.71 | ||
| Q2 24 | $-0.40 | $-0.88 | ||
| Q1 24 | $-0.24 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.4M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-115.0M | $450.0M |
| 总资产 | $339.5M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NINEOFIX
| Q4 25 | $18.4M | $82.0M | ||
| Q3 25 | $14.4M | $62.9M | ||
| Q2 25 | $14.2M | $65.6M | ||
| Q1 25 | $17.3M | $58.0M | ||
| Q4 24 | $27.9M | $83.2M | ||
| Q3 24 | $15.7M | $30.1M | ||
| Q2 24 | $26.0M | $26.4M | ||
| Q1 24 | $10.2M | $27.0M |
总债务NINEOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益NINEOFIX
| Q4 25 | $-115.0M | $450.0M | ||
| Q3 25 | $-95.9M | $442.5M | ||
| Q2 25 | $-81.7M | $458.3M | ||
| Q1 25 | $-72.1M | $458.3M | ||
| Q4 24 | $-66.1M | $503.1M | ||
| Q3 24 | $-57.6M | $525.9M | ||
| Q2 24 | $-49.7M | $546.0M | ||
| Q1 24 | $-43.3M | $570.3M |
总资产NINEOFIX
| Q4 25 | $339.5M | $850.6M | ||
| Q3 25 | $340.7M | $832.6M | ||
| Q2 25 | $361.2M | $837.2M | ||
| Q1 25 | $359.2M | $823.1M | ||
| Q4 24 | $360.1M | $893.3M | ||
| Q3 24 | $353.2M | $867.9M | ||
| Q2 24 | $381.7M | $882.0M | ||
| Q1 24 | $380.4M | $906.0M |
负债/权益比NINEOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.2M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-4.8M | $16.8M |
| 自由现金流率自由现金流/营收 | -3.6% | 7.6% |
| 资本支出强度资本支出/营收 | 2.0% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-23.3M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流NINEOFIX
| Q4 25 | $-2.2M | $27.7M | ||
| Q3 25 | $-9.9M | $12.4M | ||
| Q2 25 | $10.1M | $11.6M | ||
| Q1 25 | $-5.3M | $-18.4M | ||
| Q4 24 | $15.0M | $23.7M | ||
| Q3 24 | $-5.8M | $11.7M | ||
| Q2 24 | $12.9M | $9.0M | ||
| Q1 24 | $-8.8M | $-18.6M |
自由现金流NINEOFIX
| Q4 25 | $-4.8M | $16.8M | ||
| Q3 25 | $-13.4M | $2.5M | ||
| Q2 25 | $4.2M | $4.5M | ||
| Q1 25 | $-9.3M | $-25.1M | ||
| Q4 24 | $11.8M | $15.2M | ||
| Q3 24 | $-9.3M | $6.3M | ||
| Q2 24 | $10.3M | $-360.0K | ||
| Q1 24 | $-14.3M | $-29.1M |
自由现金流率NINEOFIX
| Q4 25 | -3.6% | 7.6% | ||
| Q3 25 | -10.2% | 1.2% | ||
| Q2 25 | 2.9% | 2.2% | ||
| Q1 25 | -6.2% | -13.0% | ||
| Q4 24 | 8.3% | 7.0% | ||
| Q3 24 | -6.7% | 3.2% | ||
| Q2 24 | 7.7% | -0.2% | ||
| Q1 24 | -10.1% | -15.4% |
资本支出强度NINEOFIX
| Q4 25 | 2.0% | 4.9% | ||
| Q3 25 | 2.6% | 4.8% | ||
| Q2 25 | 4.0% | 3.5% | ||
| Q1 25 | 2.6% | 3.5% | ||
| Q4 24 | 2.3% | 4.0% | ||
| Q3 24 | 2.5% | 2.7% | ||
| Q2 24 | 2.0% | 4.7% | ||
| Q1 24 | 3.9% | 5.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NINE
| Cement | $52.6M | 40% |
| Tool Revenue | $28.6M | 22% |
| Coiled Tubing | $25.8M | 20% |
| Wireline | $25.1M | 19% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
